Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Dr Ilson Talks Current Role of Immunotherapy in GEJ, GI Cancer- Part II
Videos
03/24/2021
In part 2 of this video series, David Ilson, MD, PhD, discusses approvals and advancements in the immunotherapy space for GEJ/GI cancer.
In part 2 of this video series, David Ilson, MD, PhD, discusses approvals and advancements in the immunotherapy space for GEJ/GI cancer.
In part 2 of this video series,...
03/24/2021
Oncology
Early On-Set CRC: A Biologically Distinct Threat? - Part II
Videos
03/15/2021
In part 2 of this series, Andrea Cercek, MD, discusses the clinical findings, molecular drivers/alterations, and further research for "Early On-Set Colorectal Cancer: A Biologically Distinct Threat?".
In part 2 of this series, Andrea Cercek, MD, discusses the clinical findings, molecular drivers/alterations, and further research for "Early On-Set Colorectal Cancer: A Biologically Distinct Threat?".
In part 2 of this series, Andrea...
03/15/2021
Oncology
Early On-Set CRC: A Biologically Distinct Threat? - Part I
Videos
03/15/2021
In part 1 of this video series, Andrea Cercek, MD, discusses the background and possible association of hereditary/environmental factors in early-onset CRC.
In part 1 of this video series, Andrea Cercek, MD, discusses the background and possible association of hereditary/environmental factors in early-onset CRC.
In part 1 of this video series,...
03/15/2021
Oncology
Dr Shitara Talks Trastuzumab Deruxtecan for Treatment in HER2-Positive Gastric Cancer
Podcasts
02/17/2021
Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, discusses trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer, an approval based on results following the DESTINY-Gastric01 study.
Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, discusses trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer, an approval based on results following the DESTINY-Gastric01 study.
Kohei Shitara, MD, National...
02/17/2021
Oncology
Dr Harris Highlights Multi-Platform Profiling With Biospecimens in Biliary Tract Cancer
Videos
02/08/2021
William Harris, MD, discusses a feasibility study on using biospecimen-based multi-platform profiling for patients with resected biliary tract cancer.
William Harris, MD, discusses a feasibility study on using biospecimen-based multi-platform profiling for patients with resected biliary tract cancer.
William Harris, MD, discusses a...
02/08/2021
Oncology
Videos
01/26/2021
Adam Diehl, MD, discusses an ongoing study assessing the ability to obtain NGS, ctDNA monitoring, and organoid drug sensitivity screening in patients with resected localized biliary tract cancer.
Adam Diehl, MD, discusses an ongoing study assessing the ability to obtain NGS, ctDNA monitoring, and organoid drug sensitivity screening in patients with resected localized biliary tract cancer.
Adam Diehl, MD, discusses an...
01/26/2021
Oncology
Dr King Highlights Progress of Ongoing Feasibility Study for Biliary Tract Cancer
Videos
01/26/2021
Gentry King, MD, discusses an ongoing feasibility study on multiomic platform-based testing in patients with localized and resectable biliary tract cancers.
Gentry King, MD, discusses an ongoing feasibility study on multiomic platform-based testing in patients with localized and resectable biliary tract cancers.
Gentry King, MD, discusses an...
01/26/2021
Oncology
Andres Cervantes, MD, PhD, Discusses Trastuzamab Deruxtecan as Emerging Therapy for Gastric Cancer
Podcasts
01/19/2021
Dr Cervantes highlights the significance of the DESTINY-Gastric01 trial and discusses new advancements in the treatment of HER2+ gastric cancer.
Dr Cervantes highlights the significance of the DESTINY-Gastric01 trial and discusses new advancements in the treatment of HER2+ gastric cancer.
Dr Cervantes highlights the...
01/19/2021
Oncology
Katrina Pedersen, MD, MS, Provides an Overview of Small Bowel Adenocarcinoma
Videos
12/15/2020
Dr Pedersen discusses the history of small bowel adenocarcinoma, and phase 2 research informing the evolving treatment landscape for this disease.
Dr Pedersen discusses the history of small bowel adenocarcinoma, and phase 2 research informing the evolving treatment landscape for this disease.
Dr Pedersen discusses the...
12/15/2020
Oncology
Katrina Pedersen, MD, Discusses Findings of the RAPIDO Trial for Locally Advanced Rectal Cancer
Videos
11/20/2020
Dr Pedersen talks about how short-course neoadjuvant chemotherapy improved outcomes over standard treatment in patients with locally advanced rectal cancer in the phase 3 RAPIDO trial.
Dr Pedersen talks about how short-course neoadjuvant chemotherapy improved outcomes over standard treatment in patients with locally advanced rectal cancer in the phase 3 RAPIDO trial.
Dr Pedersen talks about how...
11/20/2020
Oncology

Advertisement

Advertisement

Advertisement

Advertisement